Page last updated: 2024-10-31

mitotane and Multiple Endocrine Neoplasia Type 1

mitotane has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Multiple Endocrine Neoplasia Type 1: A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).

Research Excerpts

ExcerptRelevanceReference
"Multiple endocrine neoplasia type 1 was diagnosed in a 12-year-old male crossbred dog."1.31Multiple endocrine neoplasia type 1 in a crossbred dog. ( Alley, MR; Burbidge, HM; Guildford, WG; Jones, BR; Walker, MC, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walker, MC1
Jones, BR1
Guildford, WG1
Burbidge, HM1
Alley, MR1

Other Studies

1 other study available for mitotane and Multiple Endocrine Neoplasia Type 1

ArticleYear
Multiple endocrine neoplasia type 1 in a crossbred dog.
    The Journal of small animal practice, 2000, Volume: 41, Issue:2

    Topics: Adenoma; Animals; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Dog Diseases; Dogs; Male

2000